Effectiveness of Trimetazidine in Patients with Stable Angina Pectoris of Various Durations: Results from ODA

INTRODUCTION: Trimetazidine (TMZ) is an antianginal agent that acts directly at the myocardial cell level and which is now available in a once-daily (od) formulation. METHODS: ODA, a 3-month, observational, multicenter study in Russia, assessed the effectiveness and tolerability of TMZ 80 mg od in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Glezer, Maria G., Vygodin, Vladimir A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584693/
https://www.ncbi.nlm.nih.gov/pubmed/32430799
http://dx.doi.org/10.1007/s40119-020-00174-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584693/
https://www.ncbi.nlm.nih.gov/pubmed/32430799
http://dx.doi.org/10.1007/s40119-020-00174-7

Ejemplares similares